This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

EU top judges to rule on Romanian plasma therapy cartel dispute

By Anna Ferrari ( February 13, 2026, 14:32 GMT | Insight) -- Romania’s highest court has asked EU top judges to rule in a case involving biopharma company Kedrion, seeking clarification on when trade association discussions may amount to cartels. The referral follows an antitrust decision fining Kedrion and four other drugmakers for coordinating to limit Romania’s immunoglobulins supply, in a bid to pressure authorities to suspend a clawback tax on blood-derived medicines.Romania’s highest court has asked the EU’s top judges to rule in a case involving biopharma company Kedrion, according to a newly published document on the EU court’s website outlining the key issues. The EU court’s decision is expected to clarify when discussions within trade associations may qualify as cartels....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections